Varian Announces First Participant Treated in RADIATE-VT Clinical Trial of Cardiac Radioablation for Patients with Refractory Ventricular Tachycardia

Cardiac RADIoablation versus repeat catheter Ablation: a pivotal randomized clinical Trial Evaluating safety and efficacy for patients with high-risk refractory Ventricular Tachycardia (RADIATE-VT) PALO ALTO, Calif., May 19, 2023 /PRNewswire/ — Varian, a Siemens Healthineers company,…


ADVERTISEMENT — Advertise With Biotech Networks